Explore Desoxypipradrol | PiHKAL · info

Exploring Desoxypipradrol. To explore a different substance…

Names

2-DPMP
Desoxypipradrol
2-Diphenylmethylpiperidine

IUPAC name

2-(Diphenylmethyl)piperidine

ID 557 · Formula C₁₈H₂₁N · Molecular weight 251.366

InChI InChI=1S/C18H21N/c1-3-9-15(10-4-1)18(16-11-5-2-6-12-16)17-13-7-8-14-19-17/h1-6,9-12,17-19H,7-8,13-14H2

InChI Key RWTNXJXZVGHMGI-UHFFFAOYSA-N This stereoisomer Any stereoisomer

SMILES C1CCC(NC1)C(c1ccccc1)c1ccccc1

ChemSpider 141045
PubChem 160506
Wikidata Q414480
Wikipedia Desoxypipradrol
Wikipedia, see also List of methylphenidate analogues
PsychonautWiki Desoxypipradol
Project Response 2-DPMP (1104-14A)
swgdrug.org Desoxypipradrol

Phenethylamine: Von der Strucktur zur Funktion Desoxypipradrol: 3.0 (51) 76, 77 · 3.8 (19) 168 · 3.12 (59) 240, 241

Corkery, JM; Elliott, S; Schifano, F; Corazza, O; Ghodse, AH. 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review. Prog. Neuro-Psychopharmacol. Biol. Psych., 3 Dec 2012, 39 (2), 253–258. 347 kB. https://doi.org/10.1016/j.pnpbp.2012.05.021

Iversen, LL. Consideration of desoxypipradrol (2-DPMP) and related pipradrol compounds, Advisory Council on the Misuse of Drugs, 13 Sep 2011. 494 kB.

Wood, DM; Dargan, PI. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin. Toxicol., 1 Sep 2012, 50 (8), 727–732. 117 kB. https://doi.org/10.3109/15563650.2012.716158

Iversen, L; Gibbons, S; Treble, R; Setola, V; Huang, X; Roth, BL. Neurochemical profiles of some novel psychoactive substances. Eur. J. Pharmacol., 30 Jan 2013, 700 (1–3), 147–151. 490 kB. https://doi.org/10.1016/j.ejphar.2012.12.006

EMCDDA. New drugs in Europe, 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Apr 2012. 401 kB.

EMCDDA. New drugs in Europe, 2010, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2011. 700 kB.

Kavanagh, PV; Power, JD. New psychoactive substances legislation in Ireland – Perspectives from academia. Drug Test. Anal., 1 Jul 2014, 6 (7-8), 884-891. 1.2 MB. https://doi.org/10.1002/dta.1598

EMCDDA. New drugs in Europe, 2009, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2010. 321 kB. #3

Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics. Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S1 Other 2-DPMP

Simmler, LD; Rickli, A; Schramm, Y; Hoener, MC; Liechti, ME. Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives. Biochem. Pharmacol., 15 Mar 2014, 88 (2), 237–244. 504 kB. https://doi.org/10.1016/j.bcp.2014.01.024 #2-DPMP

1486

10874

1,2-DEPy · DPPy

2,2-DEPy

12023

12084

12086

12096

PAT

7 Dec 2019 · · Isomer Design